ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
  • Abstract Number: 255
    Pain As Predictor of Organ Involvement in Fabry Disease
  • Abstract Number: 258
    Pain Characteristics Among Patients with Rheumatoid Arthritis in the Context of Patient-Physician Discordance in Disease Activity Assessments
  • Abstract Number: 1402
    Parameters of Periodontitis Correlate with Anti-Citrullinated Protein Antibodies and P. Gingivalis Antibody Titers in Patients with Early or Chronic Rheumatoid Arthritis
  • Abstract Number: 358
    Parity and Severity of ACPA-Positive/Negative Rheumatoid Arthritis. Results from the Swedish EIRA Study
  • Abstract Number: 1000
    Pathogenic Role of CXC Chemokine receptor 3-Positive B Cells in Bone Destruction of Rheumatoid Arthritis
  • Abstract Number: 1255
    Pathogenic Role of Tyrosyl–Transfer RNA Synthetase in Anti-Synthetase Syndrome
  • Abstract Number: 498
    Patient Experience with Initiation of SQ and Oral MTX
  • Abstract Number: 2033
    Patient Factors Associated with Oral Glucocorticoid Prescribing Patterns in UK Primary Care for Patients with Rheumatoid Arthritis
  • Abstract Number: 1380
    Patient Global Impression of Change for Patient Reported Outcomes in Rheumatoid Arthritis: Impact of Comorbidities
  • Abstract Number: 1287
    Patient Perspective of the Main Health Concerns and Needs of Living with Hand Osteoarthritis
  • Abstract Number: 1507
    Patient Perspectives on the Introduction of Subsequent Entry Biologics in Canada
  • Abstract Number: 2768
    Patient Reported Outcomes and Acute Phase Reactants in  Polymyalgia Rheumatica in Patients Treated with Prednisone Versus Modified-Release Prednisone
  • Abstract Number: 108
    Patient Reported Outcomes Following Total Knee Arthroplasty in Rheumatoid Arthritis and Osteoarthritis
  • Abstract Number: 106
    Patient Reported Outcomes Following Upper Extremity Arthroplasties in RA -a Report from the Swedish National Register of Rheuma Surgery (RAKIR)
  • Abstract Number: 2967
    Patient Reported Pain By the Paindetect Questionnaire Reveals Multimodal Elements to Pain Perception in Rheumatoid Arthritis
  • Abstract Number: 2421
    Patient Treatment Goals in Rheumatoid Arthritis: Results of Focus Groups Among Rheumatologists, English and Spanish-Speaking Patients
  • Abstract Number: 428
    Patient-Physician Discordance of Disease Activity Assessments Predicts Inadequate Treatment Response in Early Rheumatoid Arthritis
  • Abstract Number: 300
    Patient-Reported Joint Count in Juvenile Idiopathic Arthritis: The Reliability of a Mannequin Format
  • Abstract Number: 2486
    Patient-Reported Outcomes Following 12 Months of Therapy with Abatacept (Plus Methotrexate or as Monotherapy) or Methotrexate and up to 6 Months after Treatment Withdrawal in Patients with Early Rheumatoid Arthritis
  • Abstract Number: 492
    Patient-Reported Outcomes from a Canadian Study of Patients Taking Methotrexate and Etanercept
  • Abstract Number: 289
    Patient-Reported Outcomes in Children with Moderately to Severely Active Polyarticular or Polyarticular-Course Juvenile Idiopathic Arthritis Who Are Prescribed and Treated with Adalimumab
  • Abstract Number: 2520
    Patient, Genetic and Disease Factors Influence the Response to the Disease Modifying Anti-Rheumatic Drug Leflunomide
  • Abstract Number: 2971
    Patient’s Self-Monitoring Via Smartphone: The Compass Study Correlation Between Patient Self-Assessment of Rheumatoid Arthritis Disease Activity Via Smartphone Technology and Physicians’ Validated Scores
  • Abstract Number: 1881
    Patients Who Fail Biologics Are More Likely to Have Concomitant Fibromyalgia
  • Abstract Number: 1466
    Patients with Active Rheumatoid Arthritis Display an Expanded Population of GM-CSF Expressing Peripheral B Cells
  • Abstract Number: 579
    Patients with Ankylosing Spondylitis Do Not Adapt to Their Disease: Evidence from the ‘then Test’ in Patients Treated with TNF-Inhibitors
  • Abstract Number: 2135
    Patients with Moderate Disease Activity in the First 5 Years of Rheumatoid Arthritis Still Progress Radiographically Despite Conventional Disease Modifying Therapy
  • Abstract Number: 2593
    Patients with Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis Demonstrate the Same Clinical Disease Course over Two Years: Results from the Gespic Cohort
  • Abstract Number: 589
    Patients with Nr-Axspa Show a Statistically Higher Disease Burden in Clinical Practice Compared with Patients with Radiographic Axial Spa
  • Abstract Number: 1274
    Patients with Osteoarthritis Do NOT Have Increased Risk of Cardiovascular Disease in Ullensaker Community in Norway
  • Abstract Number: 1059
    Patients with RA from Wealthier Countries Perform Better on Clinical Disease Activity Measures, but Tend to Show Worse Person Reported Outcomes
  • Abstract Number: 2721
    Patients’ Perspective of Skin Involvement in Systemic Sclerosis
  • Abstract Number: 2386
    Patients’ Interpretations of Rheumatoid Arthritis Model Disease States in a Safety-Net Rheumatology Clinic
  • Abstract Number: 290
    Patterns of Active Joint Involvement in JIA
  • Abstract Number: 2112
    Patterns of Medication Use Before, During, and After Pregnancy Among Women with Systematic Lupus Erythematosus: A Population-Based Study
  • Abstract Number: 519
    Patterns of Tocilizumab Use and Safety in Patients with Rheumatoid Arthritis: Interim Results from a Multinational Observational Study
  • Abstract Number: 1162
    Patterns of Use of Long-Term (> 5 Years) Oral Bisphophonate Prescription Among Primary Care Providers and Rheumatologists for the Treatment of Osteopenia and Osteoporosis in a Veteran Population
  • Abstract Number: 125
    PD Signal Detected By Ultrasonography Relates to Joint Destruction in Rheumatoid Arthritis Under Biologics Therapy in Real World
  • Abstract Number: 79
    PECAM-1 GENE Polymorphisms and Soluble PECAM-1 LEVEL in Rheumatoid Arthritis and Systemic LUPUS Erythematosus Patients Is There a Link with Clinical Atherosclerotic Events?
  • Abstract Number: 1224
    Pegloticase for Tophus Debulking: Comparison of Dual Energy Computerized Tomography (DECT), Musculoskeletal Ultrasound (MSK-US) and Topographic Caliper Measurement for Assessing Debulking Rate
  • Abstract Number: 2331
    People’s Views, Beliefs and Experiences of Exercise for Chronic Hip and Knee Pain: Cochrane Review with Qualitative Synthesis
  • Abstract Number: 641
    Peptidylarginine Deiminase Inhibition Mitigates NET Formation and Protects Against Kidney, Skin, and Vascular Disease in Lupus-Prone MRL/Lpr Mice
  • Abstract Number: 2046
    Perceived Discrimination in Individuals with Radiographic Knee and Hip Osteoarthritis
  • Abstract Number: 2267
    Percentage of Women Achieving Non-Osteoporotic BMD T-Scores at the Spine and Hip over 8 Years of Denosumab Treatment
  • Abstract Number: 6
    Performance Evaluation and Clinical Associations of the Aphl ELISA Compared to Criteria Antiphospholipid Immunoassays in Lupus Patients
  • Abstract Number: 2041
    Performance of a Two-Step Latent Tuberculosis Screening Algorithm in Patients with Rheumatoid Arthritis, Psoriatic Arthritis or Ankylosing Spondylitis Prior to Treatment with Tumor Necrosis Alpha Inhibitors: Prospective Observational Data from the Biorx.Si Registry, 2014 Update
  • Abstract Number: 15
    Performance of an Automated Chemiluminescence Assay for Anti-Cardiolipin and Anti-Beta2glycoprotein I Antibodies Detection in a Cohort of 400 Clinically Characterized Consecutive Routine Samples
  • Abstract Number: 158
    Performance of Joint Ultrasonography in the Diagnosis of Suspected Acute Crystal Arthritis : Results of a Prospective Study of 112 Patients
  • Abstract Number: 2014
    Performance of Self-Reported Measures for Periodontitis in Rheumatoid Arthritis and Osteoarthritis
  • Abstract Number: 2719
    Performance of the New ACR Criteria in Systemic Sclerosis: A Multicenter Study
  • Abstract Number: 2535
    Performance of the Ocular Staining Score (OSS) Vs. the Van Bijsterveld Score in the Assessment of Sjögren’s Syndrome-Related Keratoconjunctivitis Sicca
  • Abstract Number: 731
    Performance of the Old ACR and the New ACR-EULAR Systemic Sclerosis Classification Criteria in Patients with Limited Cutaneous Disease: Effect on the Ascertainment of Severe Pulmonary Arterial Hypertension
  • Abstract Number: 1234
    Periodic Fever Syndromes in an Academic Medical Center
  • Abstract Number: 1426
    Periodontal disease and Clinical Activity of Rheumatoid Arthritis Patients
  • Abstract Number: 1393
    Periodontal Disease and Its Impact on Structural Joint Damage in a Rheumatoid Arthritis Peruvian Population
  • Abstract Number: 603
    Periostin May Have a Role in Ankylosing Spondylitis and It Is Associated with Wnt Signalling Pathway Regulators
  • Abstract Number: 1719
    Periostin May Promote Productin of Extracellular Matrix By Modulating TGF-β Signaling in Human Skin Fibroblasts
  • Abstract Number: 799
    Peripheral Arterial Disease in Patients with Giant Cell Arteritis: A Systematic Review and Meta-Analysis
  • Abstract Number: 1698
    Peripheral Blood Eosinophil Counts Increase in Patients with Systemic Sclerosis and Associated with Its Disease Severity
  • Abstract Number: 1754
    Peripheral CD5+ b-Cells in ANCA-Associated Vasculitis
  • Abstract Number: 1853
    Persistence and Predictors of Biologic TNFi Therapy Among Biologic naïve Psoriatic Arthritis Patients in a US Registry
  • Abstract Number: 1569
    Persistence of Biologic Therapy in Psoriatic Disease: Results from the Psoriasis Longitudinal Assessment and Registry
  • Abstract Number: 1594
    Persistence of Low Disease Activity after Tumor Necrosis Factor Inhibitor Withdrawal in Patients with Psoriatic Arthritis
  • Abstract Number: 2494
    Persistence on Single Disease Modifying Anti-Rheumatic Drug Therapy in US Veterans with Rheumatoid Arthritis Is Extremely Rare
  • Abstract Number: 2156
    Persistent Arthralgia Following Chikungunya Fever
  • Abstract Number: 2008
    Personalized Risk Education for Rheumatoid Arthritis Improves Self-Perceived Risk Accuracy and Risk Factor Knowledge in First-Degree Relatives
  • Abstract Number: 2771
    PET-CT Imaging and Association of Ferritin Autoantibodies in Polymyalgia Rheumatica
  • Abstract Number: 2364
    PET-CT Imaging of Joints: A Quantitative Tool for Developing Novel Anti-Inflammatory Drugs
  • Abstract Number: 797
    PET/CT for the Diagnosis of Giant Cell Arteritis: A Prospective Study
  • Abstract Number: 1998
    pGALS Training Increases Kenyan Pediatric Residents’ Confidence in Performing a Musculoskeletal Exam
  • Abstract Number: 2444
    Pharmacist-Developed Letters May Enhance Success in Obtaining Insurer Approval for Off-Label Use of Biologics
  • Abstract Number: 1945
    Pharmacodynamic Effects of the CD22-Targeted Monoclonal Antibody Epratuzumab on B Cells in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1504
    Pharmacokinetic Equivalence of ABP 501 Relative to Adalimumab: Results from a Randomized, Single-Blind, Single-Dose, Parallel Group Study in Healthy Subjects
  • Abstract Number: 1478
    Pharmacokinetics, Bioavailability and Safety of a Modified-Release Once-Daily Formulation of Tofacitinib in Healthy Volunteers
  • Abstract Number: 677
    Pharmacokinetics, Safety, and Biological Activity of Intravenously or Subcutaneously Administered Tabalumab in Subjects with Rheumatoid Arthritis or Systemic Lupus Erythematosus
  • Abstract Number: 282
    Pharmacovigilance in Juvenile Idiopathic Arthritis Patients (PHARMACHILD) Treated with Biologic Agents and/or Methotrexate. Consolidated Baseline Characteristics from Pharmachild and Other National Registries
  • Abstract Number: 1481
    Phase 1 and Phase 2 Data Confirm That GLPG0634, a Selective JAK1 Inhibitor, Has a Low Potential for Drug-Drug Interactions
  • Abstract Number: 946
    Phase 1 Study of Immunotherapy Using Autoantigen-Loaded Dendritic Cells in Patients with Anti-Citrullinated Peptide Antigen Positive Rheumatoid Arthritis
  • Abstract Number: 923
    Phenotypes of Osteoarthritis-Related Knee Pain and Their Transitions over Time: The Osteoarthritis Initiative
  • Abstract Number: 2460
    Phospho-STAT1/3 and Gene Expression Measurement in Circulating CD4+ T Cells As Diagnostic Tools in Early Autoantibody-Negative Rheumatoid Arthritis
  • Abstract Number: 2054
    Physical and Mental Functioning in Patients with Established Rheumatoid Arthritis over an 11-Year Follow-up Period: The Role of Specific Comorbidities
  • Abstract Number: 2941
    Physical Function Is Independently Associated with Mortality Among Individuals with Knee and/or Hip OA: The Johnston County Osteoarthritis Project
  • Abstract Number: 1373
    Physical Function of Patients with RA Varies Importantly Across Countries, and These Differences Are Not Attributed to GDP: Results from Multi-National Study with 17 Countries
  • Abstract Number: 44
    Physical Function, Hyperuricemia and Gout in Older Adults
  • Abstract Number: 2227
    Physical Impairment in Patients with Idiopathic Inflammatory Myopathies Is Predicted By the American College of Rheumatology Functional Status Measure
  • Abstract Number: 68
    Physical Inactivity to Activity Associated with Less Decline in Physical Function
  • Abstract Number: 209
    Physical Performance and Obesity Measures Are Associated with Tibial Cartilage Volume and Explains the Sex Difference in Cartilage Volume
  • Abstract Number: 1676
    Physical Therapy for Systemic Sclerosis: Systematic Review and Meta-Analysis
  • Abstract Number: 2367
    Physician Awareness of Suboptimal Patient Adherence to MTX: Results from a Large U.S. Rheumatoid Arthritis Registry
  • Abstract Number: 1990
    Pilot Musculoskeletal Workshop for Internal Medicine Residents
  • Abstract Number: 2003
    Pilot Study of a Web-Based Module on Gout
  • Abstract Number: 2202
    Pilot Study of Tocilizumab in Patients with Erdheim-Chester Disease
  • Abstract Number: 2236
    Plant–Derived Products Are Effective for Treatment of OA Pain and Safer Than Other Active Therapies
  • Abstract Number: 1200
    Plasma Levels of Pattern Recognition Molecules of the Lectin Pathway Are Altered in SLE Patients
  • Abstract Number: 2091
    Plasma Microparticle Protein Features Distinctively Classify Systemic Lupus Erythematosus and Systemic Sclerosis and Their Clinical Phenotype
  • Abstract Number: 2745
    Plasma of Patients with Active Behçet´s Disease (BD) Increases Neutrophil Extracellular Trap Formation, Oxidative Metabolism and NADPH-Oxidase Expression in Normal and BD Neutrophils, and Carries Several Neutrophil Stimulating Factors
  • Abstract Number: 1779
    Plasmapheresis Therapy in ANCA-Associated Vasculitides: A Single-Center Retrospective Analysis of Renal Outcome and Mortality
  • Abstract Number: 1727
    Poly(ADP-ribose) Polymerase-1 (PARP-1) Suppresses the Profibrotic Effects of Transforming Growth Factor â in Systemic Sclerosis
  • Abstract Number: 2958
    Polygenic Analysis of Transport, Metabolism and Immune Related Genomic Compartments in Serum Urate and Gout
  • Abstract Number: 2742
    Polymorphisms in the Slam Family of Molecules Play a Role in the Development and Function of Invariant Natural Killer T Cells in New Zealand Black Mice
  • Abstract Number: 2171
    Polymorphisms in the FCN1 Gene Coding for M-Ficolin Are Associated with Disease Activity, Radiographic Damage and Are the Strongest Predictors of DAS28 Remission in 180 DMARD naïve Early Rheumatoid Arthritis Patients
  • Abstract Number: 2770
    Polymyalgia Rheumatica Relapse and “Silence” Large Vessel Vasculitis. Is There Any Association?
  • Abstract Number: 893
    Polysymptomatic Distress Categories for Clinical and Research Use
  • Abstract Number: 903
    Poor Adherence to Medications for Systemic Lupus Erythematosus Predicts Higher Health Care Utilization in U.S. Medicaid Beneficiaries
  • Abstract Number: 1355
    Population Management of Rheumatoid Arthritis (RA) in Rheumatology Practices: A Quality Improvement Project
  • Abstract Number: 1475
    Porphyromonas Gingivalis and Bone Turnover Biomarkers in Rheumatoid Arthritis
  • Abstract Number: 168
    Positive Association Between Tomato Consumption and Serum Urate: Investigating an Anecdotal Trigger of Gout Flares
  • Abstract Number: 2304
    Positive HLA-B27 in Juvenile Spondyloarthritis Is Associated to Early Sacroiliitis and Progression to Ankylosing Spondylitis
  • Abstract Number: 2613
    Positive Spine MRI for Inflammation Predicts Radiographic Progression in Patients with Ankylosing Spondylitis
  • Abstract Number: 94
    Possible Effects of Medicare-Only Insurance Coverage on the Use of Biologics in Patients with RA
  • Abstract Number: 2473
    Post-Marketing Surveillance of Efficacy and Safety of Tacrolimus Add-on Therapy in Japanese Rheumatoid Arthritis Patients Who Failed to Show an Adequate Response to Biological Dmards : Interim Analysis
  • Abstract Number: 2887
    Post-Menopausal Factors and the Risk of Seropositive and Seronegative Rheumatoid Arthritis Phenotypes: Results from the Nurses’ Health Study
  • Abstract Number: 2708
    Post-Occlusive Reactive Hyperemia (PORH) Test Mirrors Vascular Changes in Systemic Sclerosis (SSc):a Laser Speckle Contrast (LASCA) Study
  • Abstract Number: 752
    Potential Roles of Toll-like Receptor 4 in the Murine Models of Systemic Sclerosis
  • Abstract Number: 2214
    Power Doppler Ultrasonography for Detection of Abnormal Fascial Vascularity: A Potential Early Diagnostic Tool in Fasciitis of Dermatomyositis
  • Abstract Number: 1350
    Practice What You Preach? Suboptimal Guideline Adherence By Rheumatologists in Patients with Rheumatoid Arthritis
  • Abstract Number: 1279
    Pre-Operative Musculoskeletal Comorbidities Limit Improvement in Functional Outcomes and Hip Pain in Total Hip Arthroplasty Patients
  • Abstract Number: 193
    Pre-Operative Pain and Function: Profiles of Patients Selected for Total Knee Replacement Among Surgeons in the United States
  • Abstract Number: 2530
    PRE.MARK-TNF Test Based on Iga-Specific Autoantigens Predicts Therapy Response in Rheumatoid Arthritis Patients Treated with TNFα Inhibitors
  • Abstract Number: 2930
    Precisely Quantified Fibrosis in Labial Salivary Glands Predicts Sjögren’s Syndrome Classification in a Multiple Regression Model
  • Abstract Number: 742
    Precision of Ultrasound Skin Thickness Measurements:  Influence of Examiner and Ultrasound Transducer
  • Abstract Number: 1500
    Preclinical and Clinical Characterization of MK-8457, a Selective Spleen Tyrosine Kinase and Zeta-Chain-Associated Protein Kinase 70 Inhibitor, in Normotensive and Hypertensive Cardiovascular Models
  • Abstract Number: 1495
    Preclinical and Clinical Phase I Profile of MK-8457, a Selective Spleen Tyrosine Kinase and Zeta-Chain-Associated Protein Kinase 70 Inhibitor, Developed for the Treatment of Rheumatoid Arthritis
  • Abstract Number: 1421
    Preclinical Interstitial Lung Disease in Early Rheumatoid Arthritis
  • Abstract Number: 944
    Predict the Chance of Remission for Your RA Patient in Real Life
  • Abstract Number: 669
    Predicted Chronic Exposure and Dose Selection for Belimumab Administered Subcutaneously to SLE Patients
  • Abstract Number: 303
    Predicting Chronic Pain in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Prospective Study
  • Abstract Number: 2030
    Predicting Failure of Conventional Disease Modifying Antirheumatic Drugs in Treatment Naive Early Rheumatoid Arthritis Patients: A Single Centre Inception Prognostic Factor Cohort Study
  • Abstract Number: 1310
    Predicting Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus Patients at Diagnosis
  • Abstract Number: 1775
    Predicting Relapse in Patients with Granulomatosis with Polyangiitis – the Potential Use of Monitoring in Vitro ANCA Production
  • Abstract Number: 1920
    Predicting SLE Disease Activity in the Next Year Based on Measures of Four Gene Transcripts and Two Proteins
  • Abstract Number: 1542
    Predicting Successful Long-Term Treatment with Tumour Necrosis Factor-Alpha Inhibitors in Patients with Psoriatic Arthritis
  • Abstract Number: 1740
    Predicting the Evolution of Inflammatory Arthritis in ACPA-Positive Individuals: Can T-Cell Subsets Model Help?
  • Abstract Number: 271
    Predicting Treatment Response to Etanercept in Juvenile Idiopathic Arthritis: Results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN)
  • Abstract Number: 728
    Prediction and Impact of Attacks of Raynaud’s Phenomenon, As Judged By Patient perception 
  • Abstract Number: 730
    Prediction of Cardiac and Vascular Events in Systemic Sclerosis: Input from Endothelin-1 Type a Receptor Antibodies
  • Abstract Number: 722
    Prediction of Improvement in Skin Fibrosis in Diffuse Cutaneous Systemic Sclerosis
  • Abstract Number: 1081
    Prediction of Mortality Risk Related to Cerebrovascular Accidents in Patients with Systemic Lupus Erythematosus (SLE) vs Anti-Phospho-Lipid-Antibody (aPL) syndrome
  • Abstract Number: 2493
    Prediction of Remission and Low Disease Activity in DMARD-Refractory Patients with RA Treated with Golimumab
  • Abstract Number: 421
    Prediction of Remission By Patients and Physicians: Does the Doctor Know Best?
  • Abstract Number: 500
    Prediction of Successful Dose Reduction or Discontinuation of Adalimumab or Etanercept Using Serum Drug Levels and Antidrug Antibody Measurement
  • Abstract Number: 2758
    Predictive Factors for the Response to Infliximab Therapy in Patients with Behçet’s Disease
  • Abstract Number: 2076
    Predictive Modeling of a Fibromyalgia Diagnosis: Increasing the Accuracy Using Real World Data
  • Abstract Number: 533
    Predictive Significance of CCL21 and CXCL13 Levels in the Minor Salivary Glands of Patients with Sjögren’s Syndrome
  • Abstract Number: 551
    Predictors Associated with Rheumatologist Referral Time in Patients with Ankylosing Spondylitis
  • Abstract Number: 542
    Predictors for Cardiovascular Events in Patients with Psoriatic Arthritis – a Cohort Study
  • Abstract Number: 2496
    Predictors of ACR/EULAR Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: An Analysis from the Prospective, Observational, Biological Treatment Registry Across Canada
  • Abstract Number: 1163
    Predictors of Cholesterol and Lifestyle Discussions in Rheumatoid Arthritis Visits: Impact of Perceived RA Control and Comparison with Other Prevention Topics
  • Abstract Number: 1369
    Predictors of Deterioration in Subjective Cognition: Results from a Rheumatoid Arthritis (RA) Observational Cohort Study
  • Abstract Number: 2511
    Predictors of Discontinuation of Biologic DMARD Therapy Due to Remission in Patients with Rheumatoid Arthritis in a National Registry
  • Abstract Number: 1324
    Predictors of Disease Relapse in Juvenile Localized Scleroderma
  • Abstract Number: 2485
    Predictors of Drug-Free Remission Following Treatment with Abatacept (in Combination with Methotrexate or as Monotherapy) in Early Rheumatoid Arthritis
  • Abstract Number: 117
    Predictors of Gout Flares in a US Managed Care Setting
  • Abstract Number: 2647
    Predictors of Incident Seizure in Systemic Lupus Erythematosus
  • Abstract Number: 732
    Predictors of Inpatient Mortality in Patients with Systemic Sclerosis: A Case Control Study
  • Abstract Number: 1392
    Predictors of Long-Term Changes in Body Mass Index in Rheumatoid Arthritis
  • Abstract Number: 2222
    Predictors of Myositis Treatments Received and Associated Treatment Responses in Myovision, a National Myositis Patient Registry
  • Abstract Number: 121
    Predictors of Persistence of Power Doppler Ultrasound Synovitis in Rheumatoid Arthritis Patients in Clinical Remission
  • Abstract Number: 2754
    Predictors of Quality of Life in Behçet’s Syndrome
  • Abstract Number: 203
    Predictors of Radiographic Progression of Interphalangeal Finger Joints in Erosive Osteoarthritis: A Prospective Study
  • Abstract Number: 2139
    Predictors of Radiologic Disease Progression during the Rheumatoid Arthritis Comparison of Active Therapies Trial
  • Abstract Number: 2901
    Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis
  • Abstract Number: 2651
    Predictors of Therapeutic Outcomes in Patients with Neuropsychiatric Systemic Lupus Erythematosus
  • Abstract Number: 2587
    Predictors of Treatment Response to Tumor Necrosis Factor-Alpha Blockers in Spondyloarthritis: Systematic Review and Meta-Analysis
  • Abstract Number: 2648
    Prednisone Is a Risk Factor for Incident Depression in Systemic Lupus Erythematosus
  • Abstract Number: 689
    Prednisone, Disease Activity and Hypertension Independently Predict Cataracts in Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 1143
    Preferences of Biologic Treatment Characteristics Among Rheumatoid Arthritis Patients Who Are Current Biologic Therapy Users
  • Abstract Number: 2573
    Preferences of Patients with Spondyloarthritis for the Items of the ASAS Health Index : A Best Worst Scaling
  • Abstract Number: 301
    Pregnancies in Females with Juvenile Idiopathic Arthritis (JIA) Who Were Exposed to Biologics and/or Methotrexate – Results from a Biologic Register
  • Abstract Number: 821
    Pregnancy Outcome in Women Treated with Adalimumab for the Treatment of Rheumatoid Arthritis: An Update
  • Abstract Number: 1409
    Pregnancy Outcomes after Exposure to Certolizumab Pegol: Updated Results from Safety Surveillance
  • Abstract Number: 1840
    Pregnancy Outcomes Following Exposure to Abatacept during Pregnancy
  • Abstract Number: 1877
    Pregnancy Outcomes in SLE: Before and after
  • Abstract Number: 1908
    Pregnancy Outcomes in the Tofacitinib RA Safety Database through April 2014
  • Abstract Number: 793
    Preliminary Analysis of Histological Findings in Diagnosis of Giant Cell Arteritis Biopsy Positive Patients
  • Abstract Number: 2615
    Preliminary Assessment of a Multi-Biomarker Disease Activity Test for Axial Spondyloarthritis
  • Abstract Number: 210
    Preliminary Assessment of Predictive Validity of Cartilage Thickness MRI Biomarkers in Knee OA – the Fnih OA Biomarkers Consortium
  • Abstract Number: 2788
    Preliminary Population- Based Incidence and Prevalence Estimates of SLE: The California Lupus Surveillance Project
  • Abstract Number: 2293
    Preliminary Results from the Childhood Arthritis and Rheumatology Research Alliance Systemic JIA Consensus Treatment Plans Pilot Study
  • Abstract Number: 252
    Preliminary Validation of the Michigan Body Map
  • Abstract Number: 2670
    Premature Delivery in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 939
    Prenatal Methyl-Rich Diet Decreases Inflammation in Collagen Induced Arthritis
  • Abstract Number: 1073
    Prescription Medication Trends in Medicaid-Enrolled Pregnant Women with Rheumatoid Arthritis, Psoriasis, and Systemic Lupus Erythematosus
  • Abstract Number: 1404
    Presence and Significance of Anti-CCP Antibody in Patients with Interstitial Lung Disease with and without Clinically Apparent Rheumatoid Arthritis
  • Abstract Number: 2082
    Presence of Acrocyanosis in Patients with Joint Hypermobility
  • Abstract Number: 2551
    Presence of Germinal Centers at Baseline Is Associated with Clinical Response of Glandular Essdai Domain after Abatacept Treatment in Primary Sjogren’s Syndrome
  • Abstract Number: 1585
    Presence of Swollen and Tender Joints in Patients Fulfilling Minimal Disease Activity Criteria
  • Abstract Number: 1805
    Prevalence and Associating Factors with Atypical Femoral Fractures: An Asian Single Center Based Case-Control Study
  • Abstract Number: 390
    Prevalence and Correlates of Patient-Physician Discordance in Early Rheumatoid Arthritis
  • Abstract Number: 2441
    Prevalence and Determinants of Treatment Adherence Among Patients with Rheumatoid Arthritis
  • Abstract Number: 2720
    Prevalence and Features of Metabolic Syndrome in Systemic Sclerosis
  • Abstract Number: 1388
    Prevalence and Predictive Factors of Drug-Free and Sustained Remission in Patients with Early Arthritis
  • Abstract Number: 2640
    Prevalence and Predictors of ECG Cardiovascular Abnormalities in Lupus Patients
  • Abstract Number: 1650
    Prevalence and Prognostic Implications of IgG4 in Membranous Lupus Nephritis
  • Abstract Number: 1079
    Prevalence of Cardiac Arrhythmias in Systemic Lupus Erythematosus
  • Abstract Number: 1372
    Prevalence of Cardiovascular Disease in US Veterans with Rheumatoid Arthritis and Hepatitis C Infection
  • Abstract Number: 1550
    Prevalence of Enthesitis and Dactylitis, Impact on Disease Severity and Evolution over 12 Months in Psa Patients Treated with Anti-TNF in a Real-World Setting
  • Abstract Number: 165
    Prevalence of Gout in the Adult Population of France in 2013
  • Abstract Number: 2023
    Prevalence of Inflammatory Arthritis Conditions in the First Nations Population of Alberta
  • Abstract Number: 265
    Prevalence of Medicinal Marijuana Use Among 1000 Rheumatology Patients Attending a Community-Based Rheumatology Clinic: A Prospective Cross-Sectional Study
  • Abstract Number: 418
    Prevalence of Morning Stiffness in a US Registry Population of Rheumatoid Arthritis Patients
  • Abstract Number: 1186
    Prevalence of MRI Spinal Lesions Typical for Axial Spondyloarthritis in Patients with Inflammatory Back Pain
  • Abstract Number: 71
    Prevalence of Pain Reporting in Different Ethnic Groups in the UK: Results from a Large Biobank
  • Abstract Number: 2193
    Prevalence of Raynaud’s Phenomenon and Nailfold Capillaroscopic Abnormalities in Fabry’s Disease: A Cross-Sectional Study
  • Abstract Number: 2024
    Prevalence of Rheumatoid Arthritis in French West Indies, an African Ancestry Population. the Eppra Study
  • Abstract Number: 1285
    Prevalence of Risk Factors for Gastrointestinal Side Effects of Drugs for the Treatment of Pain in Rheumatic Diseases and the Provision of Gastroprotective Treatment – Results of a Large Non-Intervention Study
  • Abstract Number: 40
    Prevalence of Spondyloarthritis (ASAS Criteria) in First-Degree Relatives of Patients with Ankylosing Spondylitis
  • Abstract Number: 2602
    Prevalence of Subclinical Atherosclerosis in Patients with Spondyloarthritis without Clinically Evident Cardiovascular Disease Using Carotid Intima-Media Thickness
  • Abstract Number: 691
    Prevalence of Subclinical Echocardiographic Abnormalities in Patients with Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 142
    Prevalence of Subclinical Entheseal Involvement in Patients with Paediatric Inflammatory Bowel Disease: An Ultrasonographic Study
  • Abstract Number: 141
    Prevalence of Subclinical Enthesopathy in Asymptomatic First Degree Relatives of Patients with Spondyloarthritis
  • Abstract Number: 2423
    Prevalence of Subclinical Synovitis Detected By Ultrasound in Rheumatoid Arthritis and Psoriatic Arthritis Patients Receiving Anti-TNF-α Therapy with Extended Interval of Administration
  • Abstract Number: 1418
    Prevalence of Vitamin D Deficiency in Rheumatoid Arthritis
  • Abstract Number: 1706
    Prevention of SU5416-Induced Pulmonary Hypertension in a TGFβ Dependent Genetic Mouse Model of Scleroderma Using the Endothelin Receptor Antagonist Macitentan
  • Abstract Number: 2406
    Primary Non-Adherence, Associated Clinical Outcomes and Healthcare Resource Utilization Among Rheumatoid Arthritis Patients Prescribed Injectable Biologics
  • Abstract Number: 2548
    Primary Sjögren’s Syndrome Is Associated with Significant Cognitive Dysfunction
  • Abstract Number: 968
    Priming of WNT Signalling during Fibrosis Is Mediated By TGF-β Induced Axin-2 Downregulation
  • Abstract Number: 2874
    Pro-Inflammatory FcRL4+ Memory B Cells in Joints of RA Patients: Immunoglobulin Gene Characteristics and Antigen Specificity
  • Abstract Number: 34
    Pro-Nerve Growth Factor (ProNGF) Stimulates Bone Growth By Stimulating Osteoblasts and Inhibiting Osteoclast Differentiation, an Explanation for Anti-NGF-Mediated Osteonecrosis; Prongf Is a Novel Therapeutic Target for Treatment of Osteonecrosis and Charcot’s Arthropathy
  • Abstract Number: 1667
    Probability of 3 and 6 Month Complete Response in Lupus Nephritis
  • Abstract Number: 1807
    Problems with Fee for Service Payments for Academic Rheumatology Practices: A Need for Payment Reform:
  • Abstract Number: 1988
    Process Outcomes and Community-Wide Efficacy of the Amigo Inter-Institutional Mentoring Initiative within Pediatric Rheumatology
  • Abstract Number: 2569
    Profiles of Switches in Patient with Ankylosing Spondylitis: Comparing Adalimumab, Etanercept, Infliximab, Golimumab and Certolizumab
  • Abstract Number: 1975
    Profiling 14-3-3η in Human Primary Cell Based BioMAP® Disease Models Reveals a Unique Pro-Inflammatory Phenotypic Signature Consistent with RA-Inflammation Biology
  • Abstract Number: 1606
    Profiling a Broad Range of Autoantibodies in Healthy and Systemic Lupus Erythematosis   Revealed Autoantibody Patterns Associated with Autoantibody Transition and Disease Activity
  • Abstract Number: 2605
    Profiling Ankylosing Spondylitis Patients Likely to Respond to NSAID Treatment
  • Abstract Number: 830
    Profound Hypouricemia Induced in Human Subjects By Novel Bifunctional Inhibitors of Xanthine Oxidase and URAT1
  • Abstract Number: 812
    Prognosis of Clinically Inactive Takayasu’s Arteritis
  • Abstract Number: 1784
    Prognostic Factors for Interstitial Lung Disease with Microscopic Polyangiitis
  • Abstract Number: 2491
    Prognostic Factors for IV Abatacept Retention in Patients Who Have Received at Least One Prior Biologic Agent: 2-Year Results from a Prospective, International, Real-World Study
  • Abstract Number: 2981
    Prognostic Value of the Complex P2X7 Receptor-Inflammasome in Patients with Primary Sjögren’s Syndrome at Lymphoma Risk
  • Abstract Number: 3017
    Program Evaluation of ‘the Joint Clinic’: An Innovative Clinical Service for Patients with Hip or Knee Osteoarthritis
  • Abstract Number: 2723
    Programmed Death 1 Inhibits T-Cell Adhesion By Regulating Rap1
  • Abstract Number: 749
    Progranulin Overproduction Due to Fli1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor a in Systemic Sclerosis
  • Abstract Number: 2830
    Progression to and Type of Orthopaedic Surgery in Juvenile Vs. Adult-Onset Ankylosing Spondylitis
  • Abstract Number: 1693
    Progressive Disease in Systemic Sclerosis after One Year of Follow-up;  Results of a Standardized Multidisciplinary Health Care Program
  • Abstract Number: 837
    Progressive Multifocal Leukoencephalopathy Associated with Biologic Therapy in Rheumatic Diseases: Strengthening Association with Rituximab
  • Abstract Number: 1198
    Prolactin Is Locally Produced in the Synovium of Patients with Inflammatory Arthritic Diseases and Promotes Macrophage Activation
  • Abstract Number: 1947
    Prolactin Promotes Survival of Immature B Cells from MRL/Lpr Mice
  • Abstract Number: 330
    Prolactin Reduces Bone Erosion in Adjuvant-Induced Arthritis
  • Abstract Number: 1738
    Prominent Role of CCR6+ T Helper Cells in the Pathogenesis of ACPA+ Patients with Early RA
  • Abstract Number: 1238
    Proportion of Peripheral Plasmacytoid Dendritic Cells and Plasmablasts Reflects Disease Activity in IgG4-related Disease
  • Abstract Number: 85
    Protective Association of HLA-DRB1*13:02 Against MPO-ANCA Positive ANCA-Associated Vasculitis in a Japanese Population
  • Abstract Number: 2452
    Protective Effect of the IL33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
  • Abstract Number: 702
    Protein Losing Enteropathy in Systemic Lupus Erythematosus
  • Abstract Number: 868
    Protein Phosphatase 5 (PP5) Regulates Methylation Sensitive Gene Expression in CD4+ T Cells
  • Abstract Number: 93
    Protein Profiling of Secretome Human Cartilage to Identify Potential EARLY Specific Biomarkers in Osteoarthritis
  • Abstract Number: 2923
    Protein Quantification Using Mass Spectrometry Methods to Predict Response to Abatacept and Methotrexate Combination Therapy in Rheumatoid Arthritis
  • Abstract Number: 1399
    Proteinase K-like Serine Protease PCSK9 Influence on the Dyslipidemia and Endothelial Dysfunction Observed in Rheumatoid Arthritis Patients
  • Abstract Number: 1755
    Proteomic Analysis of ANCA Vasculitis Serum Reveals Broad Neutrophil Activation, Angiogenesis, and Selective Inflammatory Pathway Activation
  • Abstract Number: 1003
    Proteomic Analysis of Connexin 43 Reveals Novel Interactors Related to Osteoarthritis
  • Abstract Number: 2092
    Proteomic Phenotyping of Rheumatoid Arthritis Disease Activity
  • Abstract Number: 1979
    Pseudostarvation By AMPK Activator Therapy Is Associated with Reduced Disease Activity and Downregulation of Pro-Inflammatory Responses in Rheumatoid Arthritis (RA)
  • Abstract Number: 1562
    Psoriasis Longitudinal Assessment and Registry: Global Update upon Full Enrollment
  • Abstract Number: 2970
    Psoriatic Arthritis is Associated with Heterotopic Ossification after Total Hip Arthroplasty
  • Abstract Number: 546
    Psoriatic Arthritis Mutilans: Characteristics and Radiographic Progression
  • Abstract Number: 1411
    Psychological Distress over Time in Early Rheumatoid Arthritis: Results from a Longitudinal Study in an Early Arthritis Cohort
  • Abstract Number: 2032
    Psychological Factors Predict Adherence to Methotrexate (MTX) in Rheumatoid Arthritis (RA); Findings from a Systematic Review of Rates, Predictors and Associations with Patient Outcomes
  • Abstract Number: 1363
    Psychosocial Comorbidities Are Independently Associated with Subclinical Atherosclerosis in Rheumatoid Arthritis
  • Abstract Number: 1403
    Psychosocial Impact of Rheumatoid Arthritis Patients on Their Family Members
  • Abstract Number: 2172
    PTPN22 Promotes TLR-Induced Amelioration of Arthritis
  • Abstract Number: 778
    PTPN22 rs2476601 and Susceptibility to Biopsy Proven Giant Cell Arteritis (GCA) in an Australian Sample
  • Abstract Number: 1888
    PU.1, Mitf, and Their Novel Co-Partner, Eomes, Set up a Transcription Factor Network That Is Critical for Osteoclast Differentiation
  • Abstract Number: 1871
    Puberty and Disease Activity in JIA
  • Abstract Number: 1261
    Pulmonary Arterial Hypertension in Patients with Anti-PM-Scl Antibody
  • Abstract Number: 1296
    Pulse- Pediatric Update on Lupus in South Africa: Epidemiology and Management
  • Abstract Number: 2765
    Putative Blood Biomarkers of Reversible Cerebral Vasoconstriction Syndrome  
  • Abstract Number: 1958
    Pyrrolopyrimidine Derivatives That Inhibit Binding of BAFF to Its Receptor, BR3, Are Drug Candidates for Primary Sjögren’s Syndrome
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.